Should they wait? Two children under 3 years old infected by HCV 1b successfully treated by ledipasvir/sofosbuvir: A report of two cases
Although direct-acting antivirals (DAAs) have notably increased the sustained virological response (SVR) rates in hepatitis C virus (HCV)-infected adolescent patients, the efficacy and safety for young children under 3 years old remain unclear. Currently, no guidelines recommend DAA therapy for this...
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
KeAi Communications Co., Ltd.
2023-12-01
|
| Serie: | Liver Research |
| Ämnen: | |
| Länkar: | http://www.sciencedirect.com/science/article/pii/S2542568423000624 |